Revisión clínica | 17 OCT 17

Diagnóstico y tratamiento del vitiligo en niños

Enfoque práctico para el diagnóstico y tratamiento del vitiligo en niños.
Autor/a: Khaled Ezzedine, Nanette Silverberg Children. Pediatrics. 2016; 138(1):e20154126
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

Referencias

1. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015; 386(9988):74–84
2. Nair BK. Vitiligo—a retrospect. Int J Dermatol. 1978; 17(9):755–757
3. Gauthier YBL. Historical Aspects. Heidelberg, Germany: Springer Verlag; 2010
4. Koranne RV, Sachdeva KG. Vitiligo. Int J Dermatol. 1988; 27(10):676–681
5. Ezzedine K, Sheth V, Rodrigues M, et al; Vitiligo Working Group. Vitiligo is not a cosmetic disease. J Am Acad Dermatol. 2015; 73(5):883–885
6. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012; 51(10):1206–1212
7. Silverberg NB. The Epidemiology of Vitiligo. Curr Dermatol Rep. 2015; 4:36–43
8. Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res. 2014; 27(1):134–139
9. Ezzedine K, Diallo A, Léauté-Labrèze C, et al. Multivariate analysis of factors associated with early-onset segmental and non segmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol. 2011; 165(1):44–49
10. Shrestha R, Shrestha D, Dhakal AK, Shakya A, Shah SC, Shakya H. Spectrum of pediatric dermatoses in tertiary care center in Nepal. Nepal Med Coll J. 2012; 14(2):146–148
11. Wang X, Du J, Wang T, et al. Prevalence and clinical profile of vitiligo in China: a community-based study in six cities. Acta Derm Venereol. 2013; 93(1): 62–65
12. Chen GY, Cheng YW, Wang CY, et al. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc. 2008; 107(1):21–29
13. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol. 1977; 113(1):47–52
14. Yamamah GA, Emam HM, Abdelhamid MF, et al. Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt. Int J Dermatol. 2012; 51(10):1180–1185
15. Tey HL. A practical classification of childhood hypopigmentation disorders. Acta Derm Venereol. 2010; 90(1):6–11
16. Marinho FS, Cirino PV, Fernandes NC. Clinical epidemiological profile of vitiligo in children and adolescents. An Bras Dermatol. 2013; 88(6):1026–1028
17. Agarwal S, Gupta S, Ojha A, Sinha R. Childhood vitiligo: clinic epidemiologic profile of 268 children from the Kumaun region of Uttarakhand, India. Pediatr Dermatol. 2013; 30(3):348–353
18. Ayanlowo O, Olumide YM, Akinkugbe A, et al. Characteristics of vitiligo in Lagos, Nigeria. West Afr J Med. 2009; 28(2):118–121
19. Vora RV, Patel BB, Chaudhary AH, Mehta MJ, Pilani AP. A clinical study of vitiligo in a rural set up of Gujarat. Indian J Community Med. 2014; 39(3): 143–146
20. Alissa A, Al Eisa A, Huma R, Mulekar S. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia. Saudi Med J. 2011; 32(12):1291–1296
21. Pajvani U, Ahmad N, Wiley A, et al. The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol. 2006; 55(2):238–244
22. Kyriakis KP, Palamaras I, Tsele E, Michailides C, Terzoudi S. Case detection rates of vitiligo by
gender and age. Int J Dermatol. 2009; 48(3):328–329
23. Ezzedine K, Lim HW, Suzuki T, et al; Vitiligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012; 25(3): E1–E13
24. Nicolaidou E, Antoniou C, Miniati A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol. 2012; 66(6):954–958
25. Osborne GE, Francis ND, Bunker CB. Synchronous onset of penile lichen sclerosus and vitiligo. Br J Dermatol. 2000; 143(1):218–219
26. Ezzedine K, Gauthier Y, Léauté-Labrèze C, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol. 2011; 65(5):965–971
27. Falabella R. Surgical treatment of vitiligo: why, when and how. J Eur Acad Dermatol Venereol. 2003; 17(5): 518–520
28. Ezzedine K, Mahé A, van Geel N, et al. Hypochromic vitiligo: delineation of a new entity. Br J Dermatol. 2015; 172(3):716–721
29. Ezzedine K, Amazan E, Séneschal J, et al. Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res. 2012; 25(4):527–529
30. Mazereeuw-Hautier J, Bezio S, Mahe E, et al; Groupe de Recherche Clinique en Dermatologie Pédiatrique (GRCDP). Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. J Am Acad Dermatol. 2010; 62(6):945–949
31. Pagovich OE, Silverberg JI, Freilich E, Silverberg NB. Thyroid abnormalities in pediatric patients with vitiligo in New York City. Cutis. 2008; 81(6): 463–466
32. Silverberg N. Segmental vitiligo may not be associated with risk of autoimmune thyroiditis. Skinmed. 2011; 9(5):329–330, author reply 330
33. Tarlé RG, Nascimento LM, Mira MT, Castro CC. Vitiligo—part 1. An Bras Dermatol. 2014; 89(3):461–470
34. Naughton GK, Eisinger M, Bystryn JC. Antibodies to normal human melanocytes in vitiligo. J Exp Med. 1983; 158(1):246–251
35. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003; 16(3):208–214
36. Ezzedine K, Diallo A, Léauté-Labrèze C, et al. Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in prepubertal onset vitiligo. Br J Dermatol. 2012; 167(3):490–495
37. Silverberg JI, Silverberg NB. Association between vitiligo and atopic disorders: a pilot study. JAMA Dermatol. 2013; 149(8):983–986
38. Silverberg JI, Silverberg NB. Clinical features of vitiligo associated with comorbid autoimmune disease: a prospective survey. J Am Acad Dermatol. 2013; 69(5):824–826
39. Faria AR, Tarlé RG, Dellatorre G, Mira MT, Castro CC. Vitiligo—Part 2—classification, histopathology and treatment. An Bras Dermatol. 2014; 89(5):784–790
40. Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014; 32(4):524–530
41. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015; 386(9988):74–84
42. Diallo A, Boniface K, Jouary T, et al. Development and validation of the K-VSCOR for scoring Koebner’s phenomenon in vitiligo/non-segmental vitiligo. Pigment Cell Melanoma Res. 2013; 26(3):402–407
43. van Geel N, Speeckaert R, Taieb A, et al; VETF members. Koebner’s phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res. 2011; 24(3):564–573
44. Kim DY, Oh SH, Hann SK. Classification of segmental vitiligo on the face: clues for prognosis. Br J Dermatol. 2011; 164(5):1004–1009
45. Ducharme EE, Silverberg NB. Selected applications of technology in the pediatric dermatology office. Semin Cutan Med Surg. 2008; 27(1):94–100
46. Silverberg JI, Silverberg NB. False “highlighting” with Wood’s lamp. Pediatr Dermatol. 2014; 31(1):109–110
47. Brown MM, Chamlin SL, Smidt AC. Quality of life in pediatric dermatology. Dermatol Clin. 2013; 31(2):211–221
48. Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014; 31(3):309–318
49. Bilgiç O, Bilgiç A, Akiş HK, EskioğluF, Kiliç EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol. 2011; 36(4):360–365
50. Ramien ML, Ondrejchak S, Gendron R, et al. Quality of life in pediatric patients before and after cosmetic camoufl age of visible skin conditions. J Am Acad Dermatol. 2014; 71(5):935–940
51. Manzoni AP, Weber MB, Nagatomi AR, Pereira RL, Townsend RZ, Cestari TF. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol. 2013; 88(6):894–899
52. Taïeb A, Picardo M; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007; 20(1):27–35
53. Taieb A, Alomar A, Böhm M, et al; Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Européenne des Médecins Spécialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013; 168(1):5–19
54. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology. 1995; 190(3):223–229
55. Schallreuter KU. Q10-triggered facial vitiligo. Br J Dermatol. 2013; 169(6):1333–1336
56. Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010; 62(6): 937–941
57. Montes LF, Diaz ML, Lajous J, Garcia NJ. Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis. 1992; 50(1):39–42
58. Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study. J Am Acad Dermatol. 2011; 64(2): 445–447
59. Karadag AS, Tutal E, Ertugrul DT, Akin KO, Bilgili SG. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo. Clin Exp Dermatol. 2012; 37(1):62–64
60. Schulpis CH, Antoniou C, Michas T, Strarigos J. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol. 1989; 6(4):332–335
61. Antoniou C, Schulpis H, Michas T, et al. Vitiligo therapy with oral and topical phenylalanine with UVA exposure. Int J Dermatol. 1989; 28(8): 545–547
62. Singh A, Kanwar AJ, Parsad D, Mahajan R. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian J Dermatol Venereol Leprol. 2014; 80(1):29–35
63. van Geel N, Speeckaert R, De Wolf J, et al. Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol. 2012; 167(5):1017–1024
64. Veith W, Deleo V, Silverberg N. Medical phototherapy in childhood skin diseases. Minerva Pediatr. 2011; 63(4):327–333
65. Whitton ME, Pinart M, Batchelor J, et al. Interventions for vitiligo. Cochrane Database Syst Rev. 2015; (2):CD003263
66. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000; 42(2 Pt 1):245–253
67. Koh MJ, Mok ZR, Chong WS. Phototherapy for the treatment of vitiligo in Asian children. Pediatr
Dermatol. 2015; 32(2):192–197
68. Do JE, Shin JY, Kim DY, Hann SK, Oh SH. The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed. 2011; 27(3):147–151
69. Gawkrodger DJ, Ormerod AD, Shaw L, et al; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists; Clinical Standards Department, Royal College of Physicians of London; Cochrane Skin Group; Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008; 159 (5):1051–1076
70. Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014; 171(2):332–337
71. Krüger C, Smythe JW, Spencer JD, et al. Significant immediate and long term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea. Acta Derm Venereol. 2011; 91(2):152–159
72. Kossakowska MM, Cieścińska C, Jaszewska J, Placek WJ. Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. J Eur Acad Dermatol Venereol. 2010; 24(4):429–433
73. Ongenae K, Van Geel N, De Schepper S, Vander Haeghen Y, Naeyaert JM. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol. 2004; 14(3):177–181
74. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol. 1999; 72(pt
3):385–396
75. Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol. 1998; 23(6):243–248
76. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol. 2000; 136(3):393–399
77. Tedeschi A, Dall’Oglio F, Micali G, Schwartz RA, Janniger CK. Corrective camouflage in pediatric dermatology. Cutis. 2007; 79(2):110–112
78. Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, et al. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol. 2012; 26(6):690–695
79. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003; 148(2):373–374

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024